Repuponio, Serena C.

HRN: 12-72-19  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2025
CEFTRIAXONE 1G (VIAL)
08/08/2025
08/15/2025
IV
2g
OD
Typhoid Fever
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: